Rock Springs Capital Management LP

Insider Reports History

Entity
Company
Location
650 South Exeter Street, Suite 1070, Baltimore, MD
Signature
By: /s/ Mark Bussard, Authorized Signatory, Rock Springs Capital Management LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rock Springs Capital Management LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. 10%+ Owner Common Stock 599K $1.83M $3.05 Oct 12, 2021 Indirect
Verve Therapeutics, Inc. 10%+ Owner Common Stock 153K $1.53M $10.00 Jun 21, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1.26M $1.04M $0.83 Oct 26, 2021 Indirect
Tempest Therapeutics, Inc. 10%+ Owner Common Stock 73.7K $352K $4.78 Dec 30, 2021 Indirect
Theseus Pharmaceuticals, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Oct 12, 2021 Indirect
Verve Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jun 21, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 Oct 26, 2021 Indirect

Insider Reports Filed by Rock Springs Capital Management LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TPST Tempest Therapeutics, Inc. Dec 30, 2021 0 $0 3 Jan 10, 2022 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 26, 2021 5 $8M 4 Oct 26, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 12, 2021 5 $4M 4 Oct 14, 2021 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 5 $7.03M 4 Jun 22, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner